[HTML][HTML] Safety and efficacy of CMX001 as salvage therapy for severe adenovirus infections in immunocompromised patients

DF Florescu, SA Pergam, MN Neely, F Qiu… - Biology of Blood and …, 2012 - Elsevier
No therapeutic agent has yet been established as the definitive therapy for adenovirus
infections. We describe the clinical experience of 13 immunocompromised patients who …

[PDF][PDF] Safety and Efficacy of CMX001 as Salvage Therapy for Severe Adenovirus Infections in Immunocompromised Patients

DF Florescu, SA Pergam, MN Neely, F Qiu… - Biol Blood Marrow …, 2012 - academia.edu
Safety and Efficacy of CMX001 as Salvage Therapy for Severe Adenovirus Infections in
Immunocompromised Patients Page 1 Safety and Efficacy of CMX001 as Salvage Therapy for …

[引用][C] Safety and Efficacy of CMX001 as Salvage Therapy for Severe Adenovirus Infections in Immunocompromised Patients

DF Florescu, SA Pergam, MN Neely, F Qiu… - Biology of Blood and …, 2012 - cir.nii.ac.jp
Safety and Efficacy of CMX001 as Salvage Therapy for Severe Adenovirus Infections in
Immunocompromised Patients | CiNii Research CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ …

[HTML][HTML] Safety and Efficacy of CMX001 as Salvage Therapy for Severe Adenovirus Infections in Immunocompromised Patients

DF Florescu, SA Pergam, MN Neely, F Qiu… - Biology of Blood and …, 2012 - tctjournal.org
No therapeutic agent has yet been established as the definitive therapy for adenovirus
infections. We describe the clinical experience of 13 immunocompromised patients who …

Safety and Efficacy of CMX001 as Salvage Therapy for Severe Adenovirus Infections in Immunocompromised Patients

DF Florescu, SA Pergam, MN Neely… - Biology of Blood …, 2012 - experts.nebraska.edu
No therapeutic agent has yet been established as the definitive therapy for adenovirus
infections. We describe the clinical experience of 13 immunocompromised patients who …

[PDF][PDF] Safety and Efficacy of CMX001 as Salvage Therapy for Severe Adenovirus Infections in Immunocompromised Patients

DF Florescu, SA Pergam, MN Neely, F Qiu… - Biol Blood Marrow …, 2012 - researchgate.net
Safety and Efficacy of CMX001 as Salvage Therapy for Severe Adenovirus Infections in
Immunocompromised Patients Page 1 Safety and Efficacy of CMX001 as Salvage Therapy for …

[HTML][HTML] Safety and Efficacy of CMX001 as Salvage Therapy for Severe Adenovirus Infections in Immunocompromised Patients

DF Florescu, SA Pergam, MN Neely, F Qiu… - Biology of Blood and …, 2012 - astctjournal.org
No therapeutic agent has yet been established as the definitive therapy for adenovirus
infections. We describe the clinical experience of 13 immunocompromised patients who …

Safety and Efficacy of CMX001 as Salvage Therapy for Severe Adenovirus Infections in Immunocompromised Patients

DF Florescu, SA Pergam, MN Neely, F Qiu… - Biology of Blood and …, 2012 - infona.pl
No therapeutic agent has yet been established as the definitive therapy for adenovirus
infections. We describe the clinical experience of 13 immunocompromised patients who …

[PDF][PDF] Safety and Efficacy of CMX001 as Salvage Therapy for Severe Adenovirus Infections in Immunocompromised Patients

DF Florescu, SA Pergam, MN Neely, F Qiu… - Biol Blood Marrow …, 2012 - core.ac.uk
Safety and Efficacy of CMX001 as Salvage Therapy for Severe Adenovirus Infections in
Immunocompromised Patients Page 1 Safety and Efficacy of CMX001 as Salvage Therapy for …

[PDF][PDF] Safety and Efficacy of CMX001 as Salvage Therapy for Severe Adenovirus Infections in Immunocompromised Patients

DF Florescu, SA Pergam, MN Neely, F Qiu… - Biol Blood Marrow …, 2012 - cyberleninka.org
Safety and Efficacy of CMX001 as Salvage Therapy for Severe Adenovirus Infections in
Immunocompromised Patients Page 1 Safety and Efficacy of CMX001 as Salvage Therapy for …